Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3478719 Title: UTILISATION D'ANTICORPS ANTI-SCLÉROSTINE DANS LE TRAITEMENT DE L'OSTÉOGENÈSE IMPARFAITE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
178231908
WO application number:
GB2017053850
Type:
European patent granted for BE
Status:
Open
Publication number:
3478719
WO publication number:
WO2018115880
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
21/12/2017
Grant date:
20/01/2021
EP publication date:
08/05/2019
WO publication date:
28/06/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
20/01/2021
EP B1 publication date:
20/01/2021
EP B2 publication date:
EP B3 publication date:
18/12/2024
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/12/2037

Applicant

Name:
Mereo Biopharma 3 Limited
Legal Form:
From:
20/01/2021
Address:
4th Floor 1 Cavendish Place, London W1G 0QF, United Kingdom (GB)
To:

Agent

1

Name:
KORSTEN Marius
Legal Form:
From:
12/12/2024
Address:
New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
To:

2

Name:
KORSTEN Marius
Legal Form:
From:
02/04/2021
Address:
Technologiepark 122, 9052, ZWIJNAARDE - GENT, Belgium (BE)
To:
12/12/2024

Inventor

1

Name:
JUNKER, Uwe
Legal Form:
Address:
4070 Basel, Switzerland (CH)

2

Name:
KNEISSEL, Michaela
Legal Form:
Address:
4002 Basel, Switzerland (CH)

3

Name:
HALL, Anthony Kent
Legal Form:
Address:
2341 JB Oegstgeest, Netherlands (NL)

4

Name:
EUDY, Rena Joy
Legal Form:
Address:
West Hartford Connecticut 06117, United States (US)

5

Name:
RIGGS, Matthew Manning
Legal Form:
Address:
Haddam Connecticut 06438, United States (US)

Priority

Priority patent number:
201662437353 P
Priority date:
21/12/2016
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/22; A61K 39/395; A61P 19/08; A61K 39/00;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2021/02
Publication date:
09/04/2021
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
EP4
Journal edition number:
2024/24
Publication date:
07/02/2025
Description:
Contains data concerning granted European patents granted and republished in amended form (B2 or B3 publications) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202103
Publication date:
20/01/2021
Description:
Grant (B1)

2

Issue number:
202425
Publication date:
19/06/2024
Description:
Request for limitation Filed (Art.105a)

3

Issue number:
202448
Publication date:
27/11/2024
Description:
Request for limitation of patent allowed

4

Issue number:
202451
Publication date:
18/12/2024
Description:
Limited Patent Specification (B3)

5

Issue number:
202108
Publication date:
24/02/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
01/01/2026
Annual fee number:
9
Annual fee amount:
165 Euro
Expected payer:
Last annual fee payment date:
07/10/2024
Last annual fee paid number:
8
Last annual fee paid amount:
135 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
02/04/2021 General Document Declaration of domicile 1 PDF /5/5/7/5/8/0722085755/docs/178231908_0_generaldocument_20210403_085028182.pdf
02/04/2021 Incoming Correspondence (Email) Cover letter 1 PDF /5/5/7/5/8/0722085755/docs/178231908_1_incomingcorrespondenceelectronic_20210403_085028650.pdf
12/12/2024 Request For Change Letter and/or Form requesting a change in the Register 1 PDF /5/5/7/5/8/0722085755/docs/178231908_2_rfc_20241217_095354973.pdf
20/12/2024 Outgoing Correspondence Outgoing Correspondence 2 PDF /5/5/7/5/8/0722085755/docs/178231908_3_207902_pie.rfc.per.notif.pdf